Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
926
Price
$93.33
Total Value
$86.42K
Shares Held After
3,042
% of Holdings
23.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Quan Joanne — CHIEF MEDICAL OFFICER
Shares
1,822
Price
$93.33
Total Value
$170.04K
Shares Held After
12,817
% of Holdings
12.4%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
1,421
Price
$93.33
Total Value
$132.62K
Shares Held After
42,127
% of Holdings
3.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Radovich Peter — PRESIDENT AND COO
Shares
2,382
Price
$93.33
Total Value
$222.30K
Shares Held After
20,679
% of Holdings
10.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
7,098
Price
$93.33
Total Value
$662.42K
Shares Held After
163,733
% of Holdings
4.2%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
1,054
Price
$1.84
Total Value
$1.94K
Shares Held After
179,632
% of Holdings
0.6%
Acumen Pharmaceuticals, Inc. (ABOS)
Siemers Eric — Chief Medical Officer
Shares
895
Price
$1.82
Total Value
$1.63K
Shares Held After
255,371
% of Holdings
0.3%
Acumen Pharmaceuticals, Inc. (ABOS)
Zuga Matt — CFO & Chief Business Officer
Shares
1,687
Price
$1.86
Total Value
$3.14K
Shares Held After
304,924
% of Holdings
0.6%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
2,689
Price
$1.88
Total Value
$5.07K
Shares Held After
881,275
% of Holdings
0.3%
Acumen Pharmaceuticals, Inc. (ABOS)
Barton Russell — Chief Operating Officer
Shares
462
Price
$1.84
Total Value
$850.08
Shares Held After
205,092
% of Holdings
0.2%
Axsome Therapeutics, Inc. (AXSM)
Pizzie Nick — Chief Financial Officer
Shares
12,000
Price
$187.92
Total Value
$2.26M
Shares Held After
42,588
% of Holdings
22.0%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
18,666
Price
$5.33
Total Value
$99.51K
Shares Held After
568,560
% of Holdings
3.2%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
69,832
Price
$5.33
Total Value
$372.27K
Shares Held After
1,460,408
% of Holdings
4.6%
ABEONA THERAPEUTICS INC. (ABEO)
O'Malley Brendan M. — SVP, Chief Legal Officer
Shares
13,578
Price
$5.33
Total Value
$72.38K
Shares Held After
451,134
% of Holdings
2.9%
Cogent Biosciences, Inc. (COGT)
Fairmount Funds Management LLC — Director
Shares
3,500,000
Price
$36.40
Total Value
$127.40M
Shares Held After
5,503,418
% of Holdings
38.9%
Apogee Therapeutics, Inc. (APGE)
Fairmount Funds Management LLC — Director
Shares
1,750,000
Price
$76.30
Total Value
$133.53M
Shares Held After
298,647
% of Holdings
85.4%
Precision BioSciences, Inc. (DTIL)
Amoroso Michael — Director
Shares
34,799
Price
$4.17
Total Value
$145.11K
Shares Held After
196,154
% of Holdings
15.1%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
60,000
Price
$60.23
Total Value
$3.61M
Shares Held After
134,201
% of Holdings
30.9%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
66,477
Price
$29.44
Total Value
$1.96M
Shares Held After
19,820
% of Holdings
77.0%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
10,463
Price
$29.44
Total Value
$308.03K
Shares Held After
86,297
% of Holdings
10.8%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
7,605
Price
$29.44
Total Value
$223.89K
Shares Held After
96,760
% of Holdings
7.3%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
17,236
Price
$29.44
Total Value
$507.43K
Shares Held After
104,365
% of Holdings
14.2%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
13,690
Price
$29.44
Total Value
$403.03K
Shares Held After
121,601
% of Holdings
10.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,977
Price
$26.03
Total Value
$51.46K
Shares Held After
197,634
% of Holdings
1.0%
Allogene Therapeutics, Inc. (ALLO)
Roberts Zachary — EVP of R&D
Shares
26,269
Price
$1.56
Total Value
$40.98K
Shares Held After
616,866
% of Holdings
4.1%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
3,749
Price
$97.94
Total Value
$367.18K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
553
Price
$95.49
Total Value
$52.81K
Shares Held After
3,749
% of Holdings
12.9%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
700
Price
$109.84
Total Value
$76.89K
Shares Held After
59,634
% of Holdings
1.2%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
908
Price
$115.60
Total Value
$104.96K
Shares Held After
46,976
% of Holdings
1.9%
Avidity Biosciences, Inc. (RNAM)
Hughes Steven George — Chief Medical Officer
Shares
2,878
Price
$72.45
Total Value
$208.51K
Shares Held After
31,599
% of Holdings
8.3%
Avidity Biosciences, Inc. (RNAM)
Hughes Steven George — Chief Medical Officer
Shares
2,017
Price
$72.45
Total Value
$146.13K
Shares Held After
34,477
% of Holdings
5.5%
Avidity Biosciences, Inc. (RNAM)
Boyce Sarah — Director
Shares
7,993
Price
$72.45
Total Value
$579.09K
Shares Held After
269,007
% of Holdings
2.9%
Avidity Biosciences, Inc. (RNAM)
Boyce Sarah — Director
Shares
6,394
Price
$72.45
Total Value
$463.25K
Shares Held After
277,000
% of Holdings
2.3%
Avidity Biosciences, Inc. (RNAM)
Flanagan W. Michael — Chief Scientific Officer
Shares
2,558
Price
$72.45
Total Value
$185.33K
Shares Held After
85,093
% of Holdings
2.9%
Avidity Biosciences, Inc. (RNAM)
Flanagan W. Michael — Chief Scientific Officer
Shares
3,976
Price
$72.45
Total Value
$288.06K
Shares Held After
87,651
% of Holdings
4.3%
Avidity Biosciences, Inc. (RNAM)
MacLean Michael F — Chief Financial Officer
Shares
2,735
Price
$72.45
Total Value
$198.15K
Shares Held After
59,290
% of Holdings
4.4%
Avidity Biosciences, Inc. (RNAM)
MacLean Michael F — Chief Financial Officer
Shares
1,807
Price
$72.45
Total Value
$130.92K
Shares Held After
62,025
% of Holdings
2.8%
Avidity Biosciences, Inc. (RNAM)
LEVIN ARTHUR A — Director
Shares
1,758
Price
$72.45
Total Value
$127.37K
Shares Held After
16,562
% of Holdings
9.6%
Avidity Biosciences, Inc. (RNAM)
McCarthy Teresa — Chief Human Resources Officer
Shares
1,453
Price
$72.45
Total Value
$105.27K
Shares Held After
113,938
% of Holdings
1.3%
Avidity Biosciences, Inc. (RNAM)
McCarthy Teresa — Chief Human Resources Officer
Shares
1,476
Price
$72.45
Total Value
$106.94K
Shares Held After
115,391
% of Holdings
1.3%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
2,247
Price
$1.81
Total Value
$4.06K
Shares Held After
180,686
% of Holdings
1.2%
Acumen Pharmaceuticals, Inc. (ABOS)
Siemers Eric — Chief Medical Officer
Shares
2,331
Price
$1.80
Total Value
$4.20K
Shares Held After
256,266
% of Holdings
0.9%
Acumen Pharmaceuticals, Inc. (ABOS)
Zuga Matt — CFO & Chief Business Officer
Shares
2,473
Price
$1.81
Total Value
$4.47K
Shares Held After
306,611
% of Holdings
0.8%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
9,346
Price
$1.81
Total Value
$16.93K
Shares Held After
883,964
% of Holdings
1.0%
Acumen Pharmaceuticals, Inc. (ABOS)
Barton Russell — Chief Operating Officer
Shares
2,315
Price
$1.81
Total Value
$4.18K
Shares Held After
205,554
% of Holdings
1.1%
Axsome Therapeutics, Inc. (AXSM)
Maizel Ari — Chief Commercial Officer
Shares
7,500
Price
$184.44
Total Value
$1.38M
Shares Held After
0
% of Holdings
100.0%
CorMedix Inc. (CRMD)
Dillione Janet — Director
Shares
10,000
Price
$6.88
Total Value
$68.80K
Shares Held After
38,473
% of Holdings
20.6%
Precision BioSciences, Inc. (DTIL)
Scimeca Dario — General Counsel and Secretary
Shares
8,854
Price
$4.03
Total Value
$35.68K
Shares Held After
44,715
% of Holdings
16.5%
Precision BioSciences, Inc. (DTIL)
Kelly John Alexander — Chief Financial Officer
Shares
15,213
Price
$4.03
Total Value
$61.31K
Shares Held After
106,448
% of Holdings
12.5%
Precision BioSciences, Inc. (DTIL)
SMITH J. JEFFERSON — Chief Research Officer
Shares
10,200
Price
$4.03
Total Value
$41.11K
Shares Held After
110,184
% of Holdings
8.5%
Showing 151–200 of 1179 transactions (page 4 of 24)